MSI status and TGFBR2 or BAX mononucleotide tract mutation in colorectal cancer.

(%) indicates the proportion of cases with a specific clinical, pathologic or molecular feature among all cases, MSS/MSI-Low, TGFBR2 mutated or BAX mutated cases. CIMP, CpG island methylator phenotype; HPFS, Health Professionals Follow-up Study; MSI, microsatellite instability; MSS, microsatellite stable, NHS, Nurses' Health Study; SD, standard deviation.